SHEILA HATTON: Open Payments
NPI 1215554803 · SOUTHGATE, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,648 in 162 payments from 17 companies in 2025. Trend: 2023 $2,212 · 2024 $2,882 · 2025 $2,648
Food & beverage: $2,641Education: $8
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 17 | $374 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 23 | $343 |
| Vanda Pharmaceuticals Inc. | 12 | $301 |
| Alkermes, Inc. | 17 | $261 |
| ABBVIE INC. | 22 | $244 |
| Collegium Pharmaceutical, Inc. | 11 | $200 |
| Supernus Pharmaceuticals, Inc. | 17 | $159 |
| Axsome Therapeutics, Inc. | 7 | $150 |
| Corium, LLC | 9 | $140 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $98 |
Products named: CAPLYTA, ABILIFY MAINTENA, VRAYLAR, ARISTADA, HETLIOZ, Jornay PM, REXULTI, Qelbree.
Industry payments across MI — which companies pay providers there.
